'Octomom' doctor has medical licence revoked

By Admin
A fertility doctor who injected a woman with six times the normal number of embryos is to lose his medical licence next month. Nadya Suleman has become...

A fertility doctor who injected a woman with six times the normal number of embryos is to lose his medical licence next month.

Nadya Suleman has become famed as the Californian ‘octomom’ who in 2009 successfully gave birth to octuplets; only the second person in the US to do so.

The state’s medical board ruled that Michael Kamrava, Suleman’s fertility doctor, was guilty of being grossly negligent after he implanted an “excessive number” of embryos into Suleman.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Although Suleman became a media sensation after the successful birth, it was quickly discovered that she was an unemployed, single mother already with six children.

Kamrava helped Suleman to conceive all 14 of her children through repeated in-vitro fertility (IVF) treatments.

The Medical Board of California made the decision to revoke his medical licence as it said “public protection is paramount.”

Kamrava was also found to be negligent of his treatment of two other fertility patients; a woman who suffered severe complications after becoming pregnant with quadruplets and another who received a diagnoses of advanced ovarian cancer after undergoing fertility treatment.

The legal team representing Kamrava argued that Suleman had failed to follow through with terminating an excessive number of feotuses.

But these arguments were rejected by the board and they said: “To assign even a scintilla of responsibility to a patient who becomes pregnant and then elects not to follow through with a procedure that may jeopardise her (and possibly her family's) prized objective is troubling.”

Dr Kamrava’s licence will be officially revoked on July 1 2011

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma